Harmony Biosciences is a recipient of Life Sciences Pennsylvania’s (LSPA) 2019 Patient Impact Award. Harmony was selected as an honoree based on the company’s continued efforts to support patients living with narcolepsy.
“At Harmony, patients are at the heart of everything we do. It is an honor to be recognized by LSPA for our work to contribute to the health and wellbeing of people living with narcolepsy,” says Cate McCanless, vice president of external affairs at Harmony, in a release. “We are proud to be recognized as a company that is making a difference in the lives of patients through our continued focus on scientific innovation, advocacy, and patient education.”
LSPA’s Patient Impact Award recognizes a medicine, therapy, device, company, or organization with operations in Pennsylvania that made a significant contribution to the quality of healthcare for patients in 2019. The award was presented during LSPA’s 2020 Annual Awards Program, a broadcast documentary focusing on healthcare successes in 2019 and the efforts of the life sciences community in the fight against COVID-19.
Image ID 1851399 © Feng Yu | Dreamstime.com
